Article Details
Retrieved on: 2022-06-08 14:27:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Goldman Sachs has a buy rating and $237.00 price target on this hearing solutions company. Its analysts believe Cochlear is well-placed to at ...
Article found on: www.fool.com.au
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here